RxDoctor Payments Data

Timothy Kelly, MD

Otolaryngology · Rock Hill, SCNPI 1689731085

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.4% of the total across 34 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Sanofi at 24.0% of the total.

$1,718in general payments, 2019–2025

Across 34 payments — averaging $50.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$413
  • AstraZeneca$267
  • Inspire Medical Systems, Inc.$194
  • Medtronic$172
  • GSK$147
  • Optinose US, Inc.$112
  • plus $415 from 8 others
$99,508in research payments, 2019–2025

Across 1 payment — averaging $99,508 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • GSK$100K

What the payments were for

  • Food & beverage$1,67397%
  • Education$453%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,718 in reported general payments places this provider in the 55th percentile of 180 otolaryngology providers in South Carolina.

See all otolaryngology providers in South Carolina

Medicare billing

Part B allowed, 2024
$123,556
Medicare patients
490
Services billed
1,221

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide100$2,958
Mometasone Furoate25$895
Fluticasone Propionate51$769
Cefdinir20$338
Famotidine18$266
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav34$265
Ofloxacin16$263
Mupirocin33$238
Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid12$83
Levothyroxine Sodium15$83
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen15$53
Prednisone23$47
Cephalexin11$19

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Rock Hill

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →